• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性偏头痛患者外周血 S100B 水平无升高。

Peripheral, Interictal Serum S100B Levels are Not Increased in Chronic Migraine Patients.

机构信息

Service of Neurology, University Hospital Central de Asturias, Oviedo, Spain.

Biomedical Data Sciences Department, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.

出版信息

Headache. 2020 Sep;60(8):1705-1711. doi: 10.1111/head.13919. Epub 2020 Aug 17.

DOI:10.1111/head.13919
PMID:32804418
Abstract

BACKGROUND

The trigemino-vascular system (TVS) plays a key role in migraine pathophysiology. Glial cells are abundant in the TVS system and mainly in the trigeminal ganglion. S100B protein is a calcium-binding protein, found in the cytoplasm of glial cells in the central nervous system, which is released in response to inflammatory stimuli. Previous works analyzing S100B in migraineurs have offered contradictory results.

OBJECTIVE

In this case-control study, we analyzed serum levels of S100B as a possible biomarker of the glial TVS activation in chronic migraine (CM).

PATIENTS AND METHODS

The study group consisted of patients attending our clinic with CM and, as control groups, patients with episodic migraine (EM), cluster headache (CH) outside of a bout and healthy volunteers (HV) with no headache history. S100B levels were determined interictally in peripheral blood samples by ELISA.

RESULTS

We assessed serum samples from 43 patients with CM, 19 with EM, 29 HV (mostly women), and 22 with (CH). S100B levels in CM (mean 22.9 ± 9.8 pg/mL) were not different (P = .727) when compared to EM patients (21.2 ± 9.3 pg/mL), difference of 1.7 (95% CI -5.7 to 8.9), CH patients (22.4 ± 7.8 pg/mL), difference of 0.5 (-5.7 to 6.7), and HV (20.6 ± 8.3 pg/mL), difference of 2.3 (-3.7 to 8.3).

CONCLUSION

In contrast to other neuropeptides such as calcitonin gene-related-peptide and vasoactive intestinal peptide, which are increased in CM, interictal serum S100B levels are not elevated in these patients. According to our results, S100B levels do not seem to be a useful peripheral biomarker of the glial TVS activation in CM.

摘要

背景

三叉血管系统(TVS)在偏头痛病理生理学中起着关键作用。神经胶质细胞在 TVS 系统中含量丰富,主要存在于三叉神经节中。S100B 蛋白是一种钙结合蛋白,存在于中枢神经系统神经胶质细胞的细胞质中,在炎症刺激下释放。先前分析偏头痛患者 S100B 的研究结果相互矛盾。

目的

在这项病例对照研究中,我们分析了 S100B 血清水平,作为慢性偏头痛(CM)中神经胶质 TVS 激活的潜在生物标志物。

患者和方法

研究组由在我们诊所就诊的 CM 患者组成,对照组为发作性偏头痛(EM)患者、丛集性头痛(CH)发作间期患者和无头痛史的健康志愿者(HV)。通过 ELISA 法在患者外周血样本中测定 S100B 水平。

结果

我们评估了 43 例 CM 患者、19 例 EM 患者、29 例 HV(主要为女性)和 22 例 CH 的血清样本。CM 患者(平均 22.9±9.8 pg/mL)的 S100B 水平与 EM 患者(21.2±9.3 pg/mL)相比没有差异(P=0.727),差异为 1.7(95%CI-5.7 至 8.9),与 CH 患者(22.4±7.8 pg/mL)相比差异为 0.5(-5.7 至 6.7),与 HV(20.6±8.3 pg/mL)相比差异为 2.3(-3.7 至 8.3)。

结论

与降钙素基因相关肽和血管活性肠肽等其他神经肽不同,这些神经肽在 CM 中增加,而发作间期 S100B 血清水平在这些患者中并未升高。根据我们的结果,S100B 水平似乎不是 CM 中神经胶质 TVS 激活的有用外周生物标志物。

相似文献

1
Peripheral, Interictal Serum S100B Levels are Not Increased in Chronic Migraine Patients.慢性偏头痛患者外周血 S100B 水平无升高。
Headache. 2020 Sep;60(8):1705-1711. doi: 10.1111/head.13919. Epub 2020 Aug 17.
2
S100B and NSE in Cluster Headache - Evidence for Glial Cell Activation?S100B 和 NSE 在丛集性头痛中的研究——神经胶质细胞激活的证据?
Headache. 2020 Sep;60(8):1569-1580. doi: 10.1111/head.13864. Epub 2020 Jun 16.
3
S100B and neuron-specific enolase levels in episodic and chronic migraine.发作性和慢性偏头痛中S100B和神经元特异性烯醇化酶水平
Acta Neurol Scand. 2021 Mar;143(3):298-302. doi: 10.1111/ane.13365. Epub 2020 Nov 8.
4
No Change in Interictal PACAP Levels in Peripheral Blood in Women With Chronic Migraine.慢性偏头痛女性外周血中无肽能神经肽 PACAP 水平变化。
Headache. 2016 Oct;56(9):1448-1454. doi: 10.1111/head.12949. Epub 2016 Sep 16.
5
Is serum S100B protein an useful biomarker in migraine?血清S100B蛋白是偏头痛的一种有用生物标志物吗?
Neurol Sci. 2014 Aug;35(8):1197-201. doi: 10.1007/s10072-014-1679-7. Epub 2014 Feb 16.
6
Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.间歇期外周血 CGRP 水平升高可作为慢性偏头痛的生物标志物。
Neurology. 2013 Oct 1;81(14):1191-6. doi: 10.1212/WNL.0b013e3182a6cb72. Epub 2013 Aug 23.
7
Increased VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine.偏头痛发作之外的外周血中血管活性肠肽水平升高作为慢性偏头痛中颅副交感神经激活的潜在生物标志物。
Cephalalgia. 2015 Apr;35(4):310-6. doi: 10.1177/0333102414535111. Epub 2014 May 20.
8
Neuropeptides as a Marker for Chronic Headache.神经肽作为慢性头痛的一个标志物
Curr Pain Headache Rep. 2017 Apr;21(4):18. doi: 10.1007/s11916-017-0618-8.
9
Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice.血清 CGRP、VIP 和 PACAP 在偏头痛中的作用:在真实临床实践中慢性偏头痛患者的病例对照研究。
Mol Biol Rep. 2020 Sep;47(9):7125-7138. doi: 10.1007/s11033-020-05781-0. Epub 2020 Sep 20.
10
Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case-Control and Case-Crossover Settings: A Systematic Review and Meta-Analysis.发作性和慢性偏头痛及丛集性头痛患者血液中的血清素和神经肽:病例对照和病例交叉研究的系统评价和荟萃分析
Headache. 2020 Jun;60(6):1132-1164. doi: 10.1111/head.13802. Epub 2020 Apr 15.

引用本文的文献

1
GFAP as a marker of astrocytic damage correlated with medication overuse in migraine.胶质纤维酸性蛋白作为星形细胞损伤的标志物,与偏头痛中的药物过度使用相关。
Immunol Res. 2025 Aug 9;73(1):119. doi: 10.1007/s12026-025-09674-x.
2
Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study.慢性偏头痛患者血浆中胶质纤维酸性蛋白和神经丝轻链水平:一项多中心病例对照研究。
Neurol Sci. 2025 May;46(5):2209-2216. doi: 10.1007/s10072-025-08011-2. Epub 2025 Jan 25.
3
Serum neurofilament light chain levels in migraine patients: a monocentric case-control study in China.
偏头痛患者血清神经丝轻链水平的单中心病例对照研究。
J Headache Pain. 2023 Nov 6;24(1):149. doi: 10.1186/s10194-023-01674-2.
4
Safety and Efficacy of Zavegepant in Treating Migraine: A Systematic Review.扎韦普坦治疗偏头痛的安全性和有效性:一项系统评价
Cureus. 2023 Jul 17;15(7):e41991. doi: 10.7759/cureus.41991. eCollection 2023 Jul.
5
Exploring Novel Therapeutic Targets in the Common Pathogenic Factors in Migraine and Neuropathic Pain.探讨偏头痛和神经病理性疼痛常见致病因素中的新型治疗靶点。
Int J Mol Sci. 2023 Feb 18;24(4):4114. doi: 10.3390/ijms24044114.
6
Elevated Blood S100B Levels in Patients With Migraine: A Systematic Review and Meta-Analysis.偏头痛患者血液中S100B水平升高:一项系统评价和荟萃分析
Front Neurol. 2022 Jul 14;13:914051. doi: 10.3389/fneur.2022.914051. eCollection 2022.